Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317→Asp substitution associated with lethal hypophosphatasia

Mariko Fukushi, Norio Amizuka, Kazuto Hoshi, Hidehiro Ozawa, Hidetoshi Kumagai, Satoshi Omura, Yoshio Misumi, Yukio Ikehara, Kimimitsu Oda

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

One point mutation which converts glycine-317 to aspartate of tissue-nonspecific alkaline phosphatase (TNSALP) was reported to be associated with lethal hypophosphatasia. In order to define the molecular defect of TNSALP underlying the pathogenesis of hypophosphatasia, we have examined the biosynthesis of TNSALP with a Gly317→Asp substitution. When expressed in COS-1 cells, the mutant did not exhibit alkaline phosphatase activity at all, indicating that the replacement of glycine-317 with aspartate abolishes the catalytic activity of TNSALP. Pulse-chase experiments showed that the newly synthesized mutant failed to acquire Endo H-resistance and to reach the cell surface. Interestingly, this TNSALP mutant was found to form a disulfide-bonded high-molecular-mass aggregate and was rapidly degraded within the cell, though the mutant protein was modified by glycosylphosphatidylinositol (GPI). Lactacystin, an inhibitor of the proteasome, obstructed the degradation of the mutant protein, suggesting the involvement of proteasome as a part of quality control of TNSALP.

Original languageEnglish (US)
Pages (from-to)613-618
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume246
Issue number3
DOIs
StatePublished - May 29 1998

Fingerprint

Hypophosphatasia
Alkaline Phosphatase
Substitution reactions
Tissue
Degradation
Mutant Proteins
Aspartic Acid
Glycine
Glycosylphosphatidylinositols
Proteasome Inhibitors
COS Cells
Biosynthesis
Molecular mass
Proteasome Endopeptidase Complex
Point Mutation
Disulfides
Quality Control
Quality control
Catalyst activity
Defects

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317→Asp substitution associated with lethal hypophosphatasia. / Fukushi, Mariko; Amizuka, Norio; Hoshi, Kazuto; Ozawa, Hidehiro; Kumagai, Hidetoshi; Omura, Satoshi; Misumi, Yoshio; Ikehara, Yukio; Oda, Kimimitsu.

In: Biochemical and Biophysical Research Communications, Vol. 246, No. 3, 29.05.1998, p. 613-618.

Research output: Contribution to journalArticle

Fukushi, Mariko ; Amizuka, Norio ; Hoshi, Kazuto ; Ozawa, Hidehiro ; Kumagai, Hidetoshi ; Omura, Satoshi ; Misumi, Yoshio ; Ikehara, Yukio ; Oda, Kimimitsu. / Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317→Asp substitution associated with lethal hypophosphatasia. In: Biochemical and Biophysical Research Communications. 1998 ; Vol. 246, No. 3. pp. 613-618.
@article{261f25cdb26045e88fde1268ec5389d5,
title = "Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317→Asp substitution associated with lethal hypophosphatasia",
abstract = "One point mutation which converts glycine-317 to aspartate of tissue-nonspecific alkaline phosphatase (TNSALP) was reported to be associated with lethal hypophosphatasia. In order to define the molecular defect of TNSALP underlying the pathogenesis of hypophosphatasia, we have examined the biosynthesis of TNSALP with a Gly317→Asp substitution. When expressed in COS-1 cells, the mutant did not exhibit alkaline phosphatase activity at all, indicating that the replacement of glycine-317 with aspartate abolishes the catalytic activity of TNSALP. Pulse-chase experiments showed that the newly synthesized mutant failed to acquire Endo H-resistance and to reach the cell surface. Interestingly, this TNSALP mutant was found to form a disulfide-bonded high-molecular-mass aggregate and was rapidly degraded within the cell, though the mutant protein was modified by glycosylphosphatidylinositol (GPI). Lactacystin, an inhibitor of the proteasome, obstructed the degradation of the mutant protein, suggesting the involvement of proteasome as a part of quality control of TNSALP.",
author = "Mariko Fukushi and Norio Amizuka and Kazuto Hoshi and Hidehiro Ozawa and Hidetoshi Kumagai and Satoshi Omura and Yoshio Misumi and Yukio Ikehara and Kimimitsu Oda",
year = "1998",
month = "5",
day = "29",
doi = "10.1006/bbrc.1998.8674",
language = "English (US)",
volume = "246",
pages = "613--618",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317→Asp substitution associated with lethal hypophosphatasia

AU - Fukushi, Mariko

AU - Amizuka, Norio

AU - Hoshi, Kazuto

AU - Ozawa, Hidehiro

AU - Kumagai, Hidetoshi

AU - Omura, Satoshi

AU - Misumi, Yoshio

AU - Ikehara, Yukio

AU - Oda, Kimimitsu

PY - 1998/5/29

Y1 - 1998/5/29

N2 - One point mutation which converts glycine-317 to aspartate of tissue-nonspecific alkaline phosphatase (TNSALP) was reported to be associated with lethal hypophosphatasia. In order to define the molecular defect of TNSALP underlying the pathogenesis of hypophosphatasia, we have examined the biosynthesis of TNSALP with a Gly317→Asp substitution. When expressed in COS-1 cells, the mutant did not exhibit alkaline phosphatase activity at all, indicating that the replacement of glycine-317 with aspartate abolishes the catalytic activity of TNSALP. Pulse-chase experiments showed that the newly synthesized mutant failed to acquire Endo H-resistance and to reach the cell surface. Interestingly, this TNSALP mutant was found to form a disulfide-bonded high-molecular-mass aggregate and was rapidly degraded within the cell, though the mutant protein was modified by glycosylphosphatidylinositol (GPI). Lactacystin, an inhibitor of the proteasome, obstructed the degradation of the mutant protein, suggesting the involvement of proteasome as a part of quality control of TNSALP.

AB - One point mutation which converts glycine-317 to aspartate of tissue-nonspecific alkaline phosphatase (TNSALP) was reported to be associated with lethal hypophosphatasia. In order to define the molecular defect of TNSALP underlying the pathogenesis of hypophosphatasia, we have examined the biosynthesis of TNSALP with a Gly317→Asp substitution. When expressed in COS-1 cells, the mutant did not exhibit alkaline phosphatase activity at all, indicating that the replacement of glycine-317 with aspartate abolishes the catalytic activity of TNSALP. Pulse-chase experiments showed that the newly synthesized mutant failed to acquire Endo H-resistance and to reach the cell surface. Interestingly, this TNSALP mutant was found to form a disulfide-bonded high-molecular-mass aggregate and was rapidly degraded within the cell, though the mutant protein was modified by glycosylphosphatidylinositol (GPI). Lactacystin, an inhibitor of the proteasome, obstructed the degradation of the mutant protein, suggesting the involvement of proteasome as a part of quality control of TNSALP.

UR - http://www.scopus.com/inward/record.url?scp=17544395958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17544395958&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1998.8674

DO - 10.1006/bbrc.1998.8674

M3 - Article

C2 - 9618260

AN - SCOPUS:17544395958

VL - 246

SP - 613

EP - 618

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -